Instrument Inactif

Communiqués Sucampo Pharmaceuticals, Inc.

Actions

US8649091068

Recherche biotechnologique et médicale

Communiqués

03/01/18	Levi & Korsinsky, LLP Reminds Investors of an Investigation Concerning Whether the Sale of Sucampo Pharmaceuticals, Inc. to Mallinckrodt plc is Fair to Shareholders	BU
29/12/17	SUCAMPO PHARMACEUTICALS, INC. Former SEC Attorney Willie Briscoe Investigates Sale to Mallinckrodt plc	BU
28/12/17	CORRECTING and REPLACING Investor Alert: Levi & Korsinsky, LLP Notifies Investors of an Investigation Concerning Whether the Sale of Sucampo Pharmaceuticals, Inc. to Mallinckrodt plc is Fair to Shareholders	BU
27/12/17	SUCAMPO PHARMACEUTICALS, INC. Rigrodsky & Long, P.A. Announces Investigation of Buyout	BU
27/11/17	Sucampo Pharmaceuticals Announces its Participation at the Global Mizuho Investor Conference	GL
21/11/17	Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 29th Annual Piper Jaffray Healthcare Conference	GL
09/11/17	Sucampo to Host 2017 R&D Day on November 16 in New York	GL
01/11/17	Sucampo Reports Third Quarter 2017 Financial Results	GL
23/10/17	Sucampo Announces Third Quarter 2017 Earnings Call	GL
28/09/17	Sucampo Pharmaceuticals Announces FDA Acceptance of sNDA for AMITIZA in Children with Pediatric Functional Constipation, with Priority Review Designation	GL
28/09/17	Sucampo Pharmaceuticals Announces Presentation at Deutsche Bank’s 25th Annual Leveraged Finance Conference	GL
21/09/17	Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 2017 Leerink Partners Roundtable Series: Rare Disease & Immuno-Oncology	GL
20/09/17	Sucampo Pharmaceuticals Appoints Alex Driggs as General Counsel	GL
11/09/17	Sucampo Pharmaceuticals : Cancer Prevention Pharmaceuticals Receives $9.5 Million in Additional Funding from Sucampo Following Phase 3 Trial Progress	BU
30/08/17	Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 2017 Wells Fargo Healthcare Conference	GL
11/08/17	Sucampo Pharmaceuticals : Study Results Published in The Lancet Demonstrate Safety and Efficacy of Intrathecal VTS-270 in Niemann-Pick Disease Type C1	PU
07/08/17	Sucampo Pharmaceuticals : Drug Makers Stock Performance Review -- DURECT, Sucampo Pharma, Apricus Biosciences, and MEI Pharma	PR
02/08/17	Sucampo Reports Second Quarter 2017 Financial Results	GL
19/07/17	Sucampo Announces Second Quarter 2017 Earnings Call	GL
18/07/17	Dr. Karen Smith Joins Sucampo’s Board of Directors	GL
13/06/17	Sucampo Pharmaceuticals Announces Issuance of New Patent for VTS-270	GL
01/06/17	Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the Jefferies 2017 Global Healthcare Conference	GL
22/05/17	Sucampo Pharmaceuticals : Technical Reports on Drug Makers Stocks -- Synergy Pharma, Novo Nordisk, Apricus Biosciences, and Sucampo Pharma	PR
11/05/17	Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the Bank of America Merrill Lynch 2017 Health Care Conference	GL
03/05/17	Sucampo Reports First Quarter 2017 Financial Results	GL